FCGR2B (Fc fragment of IgG, low affinity IIb, receptor (CD32))

2002-02-01   Mary Callanan  , Dominique Leroux  

Lymphoma Research Group - Groupe de Recherche sur les Lymphomes - EMI0353, Institut Albert Bonniot, Université Joseph Fourier Grenoble 1, La Tronche 38706, France

Identity

HGNC
LOCATION
1q23.3
IMAGE
Atlas Image
LEGEND
Probe(s) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics
LOCUSID
ALIAS
CD32,CD32B,FCG2,FCGR2,FCGR2C,FcRII-c,IGFR2
FUSION GENES

DNA/RNA

Description

The FCGR2B gene spans a 15kb genomic region; Gene orientation : centromere - 3 FCGR2B 5 - telomere; 8 exons (denoted S1, S2, EC1, EC2, TM, IC1, IC2, IC3). S1 and S2 encode the signal peptide domain, EC1 and EC2 encode the extracellular domain, TM encodes the transmembrane domain and IC1, IC2, IC3 encode the intracytoplasmic region.

Transcription

1.7kb mRNA. Two alternately spliced mRNA exist in humans; FcgRIIb1 and FcgRIIb2 (a 19 aa insertion encoded by IC1 is present in b1 but not in b2).

Proteins

Note

called Fc gamma RIIB

Description

40kD transmembrane glycoprotein that possesses an intracytoplasmic Immunoreceptor Tyrosine-based Inhibition Motif (ITIM) (encoded by IC3).

Expression

B, myeloid and mast cells.

Localisation

Transmembrane.

Function

Low affinity IgG Fc receptor. Founding member ITIM family of immune inhibitory receptors. Fc gamma RIIB functions to down-regulate activatory responses mediated by Immunoreceptor Tyrosine-based Inhibition Motif (ITAM) bearing receptors such as the B-cell receptor on B cells. For example, on B-cells, negative regulation of B-cell receptor activatory signalling is initiated through co-recruitment of BCR and Fc gamma RIIB to IgG/ immune complexes. This leads to tyrosyl phosphorylation of the Fc gamma RIIB ITIM motif / recruitment of the inositol phosphatase SHIP and activation of the adaptor protein Dok - these events ultimately lead to the inhibition of ITAM-dependant Ca++ mobilisation and cellular proliferation (reduced MAPK signalling), respectively.
A proapoptotic signal through the Fc gamma RIIB transmembrane sequence has been described in conditions of homo-aggregation of Fc gamma RII on murine B cells.

Homology

Contains two immunoglobulin-like C2 domains.

Implicated in

Entity name
1q21-23 rearrangements in NHL (Nnon-Hodgkins Lymphoma)
Disease
NHL (< 5% of cases with 1q21-23 breaks)
Prognosis
It is now known that cytogenetically determined 1q21-23 breaks can target a diversity of 1q21-23 genes. Early data has suggested a poor prognosis for 1q21 rearrangements in diffuse large cell lymphoma.
Cytogenetics
Deregulation of the FCGR2B gene by chromosomal translocation was first demonstrated in 3 NHL patients that showed a t(1;22)(q22;q22) in association with a t(14;18)(q32;q21). Two further cases of NHL with rearrangements affecting the FCGR2B region have since been identified. Both cases also showed t(14;18)(see below for description). This suggests a role for this deregulation in lymphoma progression.
Hybrid gene
Dysregulation of the FCGR2B gene has been identified as a consequence of a t(1;22)(q22;q11) (3 patients) and t(1;14)(q21;q32) (1 patient). The FCGR2B coding sequence and promoter region appear to remain intact in these translocations. The principal consequence is overexpression of the Fc gamma RIIb2 isoform of Fc gamma RIIB. Deregulation of FCGR2B most likely occurs as a consequence of Ig gene transcriptional enhancer activity. Other mechanisms may exist ; an NHL patient with dup(1)(q21q25) and rearrangement in the FCGR2B region has also been identified.
Fusion protein
None
Oncogenesis
Contribution of FCGR2B deregulation to lymphoma development or progression is currently not known.

Article Bibliography

Pubmed IDLast YearTitleAuthors
106184142000The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.Callanan MB et al
117536462001Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.Chen W et al
91436871997Fc receptor biology.Daëron M et al
110218042000Immune inhibitory receptors.Ravetch JV et al

Other Information

Locus ID:

NCBI: 2213
MIM: 604590
HGNC: 3618
Ensembl: ENSG00000072694

Variants:

dbSNP: 2213
ClinVar: 2213
TCGA: ENSG00000072694
COSMIC: FCGR2B

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000072694ENST00000236937P31994
ENSG00000072694ENST00000358671P31994
ENSG00000072694ENST00000367961P31994

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
B cell receptor signaling pathwayKEGGko04662
B cell receptor signaling pathwayKEGGhsa04662
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
PhagosomeKEGGko04145
PhagosomeKEGGhsa04145
Staphylococcus aureus infectionKEGGko05150
Staphylococcus aureus infectionKEGGhsa05150
Osteoclast differentiationKEGGko04380
Osteoclast differentiationKEGGhsa04380
MeaslesKEGGko05162
MeaslesKEGGhsa05162
TuberculosisKEGGko05152
TuberculosisKEGGhsa05152
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA451743trastuzumabChemicalLiterature, MultilinkAnnotationnot associated18347005

References

Pubmed IDYearTitleCitations
348596442024Evaluation of the FCGR2B polymorphism in children with immune thrombocytopenia.0
381473162024FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.3
348596442024Evaluation of the FCGR2B polymorphism in children with immune thrombocytopenia.0
381473162024FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.3
369301022023FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma.1
369972992023Mutation of the TGN1412 anti-CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super-agonist activity.1
376110812023FcγRIIB expressed on CD8(+) T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.2
376342762023FcγRIIB expression increases during primary biliary cholangitis.1
377138712023FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.1
378449942023C-reactive protein impairs immune response of CD8(+) T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma.2
369301022023FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma.1
369972992023Mutation of the TGN1412 anti-CD28 monoclonal antibody lower hinge confers specific FcγRIIb binding and retention of super-agonist activity.1
376110812023FcγRIIB expressed on CD8(+) T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.2
376342762023FcγRIIB expression increases during primary biliary cholangitis.1
377138712023FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.1

Citation

Mary Callanan ; Dominique Leroux

FCGR2B (Fc fragment of IgG, low affinity IIb, receptor (CD32))

Atlas Genet Cytogenet Oncol Haematol. 2002-02-01

Online version: http://atlasgeneticsoncology.org/gene/397/fcgr2b-(fc-fragment-of-igg-low-affinity-iib-receptor-(cd32))